David R Lynch

The Regulation of the Disease-Causing Gene FXN

Elizabeth Mercado-Ayón, L. Ngaba, Y. Dong, 2024, Cells.

Phenotypic variation of FXN compound heterozygotes in a Friedreich ataxia cohort

C. Rummey, David R Lynch, Megan M. Shen, 2024, Annals of clinical and translational neurology.

AAV8 gene therapy reverses cardiac pathology and prevents early mortality in a mouse model of Friedreich’s ataxia

C. Fonck, F. Urbinati, Sarah M. Halawani, 2024, Molecular therapy. Methods & clinical development.

Pharmacotherapeutic strategies for Friedreich Ataxia: a review of the available data

David R Lynch, Katherine Gunther, 2024, Expert opinion on pharmacotherapy.